Immage Biotherapeutics Corp. (IMMG)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 22, 2026
Immage Biotherapeutics Company Description
Immage Biotherapeutics Corp. does not have significant business operations.
Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States.
The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015.
The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.
Immage Biotherapeutics Corp.
| Country | United States |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Zhi Cong Mou |
Contact Details
Address: 10411 Motor City Drive Bethesda, Maryland 20817 United States | |
| Phone | 866 692 2939 |
| Website | immagebio.com |
Stock Details
| Ticker Symbol | IMMG |
| Exchange | OTCMKTS |
| Fiscal Year | September - August |
| Reporting Currency | USD |
| ISIN Number | US45250J1007 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Zhi Cong Mou | Chief Executive Officer, President, Treasurer, Secretary and Director |
| Elton F. Norman CPA, Esq., J.D. | Chief Financial Officer and Director |
| Mahesh Narayanan M.S. | Chief Operating Officer and Director |